This week's Fierce Biotech is brought to you by Sartorius. Trouble viewing? Click here.
Experts’ Insights in Advanced Therapies: Dr. Qasim Rafiq of UCL
CAR-T therapies have shown tremendous clinical potential. However, the manufacturing remains challenging due to the lack of control and automation as well as process and cell product characterization during process development and manufacturing stages. In this edition of Experts’ Insights in Advanced Therapies, Dr. Qasim Rafiq, Associate Professor of Bioprocessing Engineering at UCL shares his insights from the development of an automated CAR-T expansion process. Read to find out about:
Scalable stirred-tank CAR-T cell expansion Optimizing cell product quality through process insight The future of CAR-T manufacturing to reduce batch variation, batch failure, and process cost
Published by Sartorius AG Otto-Brenner-Straße 20 37079 Goettingen, Germany Phone +49 551 308-0 Fax +49 551 308-3289 info@sartorius.com sartorius.com
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
